Photon Capital Board to Meet on May 29 to Approve FY26 Results

Photon Capital Advisors Limited has announced that its board of directors will convene on May 29, 2026, to deliberate on the company's financial performance for the recent fiscal period. The meeting is scheduled to begin at 03:00 p.m. at the company's registered office located in Jubilee Hills, Hyderabad.

Agenda for the Meeting

The primary focus of the board meeting will be the consideration and approval of the audited standalone financial results. Specifically, the directors will review the performance for the fourth quarter of the financial year, as well as the cumulative figures for the entire financial year ended March 31, 2026.

Additionally, the board is set to approve the audited standalone financial statements of the company for the financial year ended March 31, 2026. This approval is a standard regulatory requirement aimed at finalizing the company's accounts for the specified period.

Meeting Details

The following table outlines the key logistical details regarding the upcoming board meeting:

Detail	Information
Date	May 29, 2026
Time	03:00 p.m.
Venue	Plot No.90-A, Road No.9, Jubilee Hills, Hyderabad - 500 033, Telangana
Purpose	To consider audited standalone financial results for Q4 and FY26 and audited standalone financial statements for FY26

The intimation regarding this meeting was sent to the stock exchanges in compliance with Regulation 29 of the SEBI (LODR) Regulations, 2015. The company has confirmed that the meeting is being held to ensure timely disclosure of its financial performance to its shareholders and the market.

Kamath Technology LLP has submitted a disclosure to BSE Limited regarding a substantial acquisition of shares in Photon Capital Advisors Limited. The filing, made in compliance with Regulation 29(1) and 29(3) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, details the transaction that occurred on May 05, 2026. The acquirer, Nikhil Kamath, serving as the Designated Partner, confirmed the acquisition through an official letter addressed to the Corporate Relations Department of BSE Limited.

Details of the Acquisition

The acquisition involved the purchase of 2,10,000 equity shares carrying voting rights, which accounts for 7.72% of the total share capital and 4.46% of the total diluted share capital of Photon Capital Advisors Limited. Prior to this transaction, the acquirer held no shares or voting rights in the target company. The shares were acquired via preferential allotment.

Financial Breakdown

The following table summarizes the acquisition details and the resulting shareholding structure:

Description	Number	% of Total Share Capital	% of Total Diluted Share Capital
Before Acquisition
Shares carrying voting rights	Nil	Nil	Nil
Encumbered shares	Nil	Nil	Nil
Voting rights otherwise than by shares	Nil	Nil	Nil
Warrants/convertible securities	Nil	Nil	Nil
Total Before Acquisition	Nil	Nil	Nil
Acquisition Details
Shares carrying voting rights acquired	2,10,000	7.72	4.46
Warrants/convertible securities acquired	2,25,000	NA	4.78
Total Acquisition	4,35,000	7.72	9.24
After Acquisition
Shares carrying voting rights	2,10,000	7.72	4.46
Encumbered shares	Nil	Nil	Nil
Voting rights otherwise than by shares	Nil	Nil	Nil
Warrants/convertible securities	2,25,000	NA	4.78
Total After Acquisition	4,35,000	7.72	9.24

Capital Structure Changes

The acquisition has altered the equity share capital structure of Photon Capital Advisors Limited. Before the acquisition, the equity share capital stood at Rs. 1,51,36,940, divided into 15,13,694 equity shares of Rs.10 each. Following the transaction, the equity share capital increased to Rs. 2,72,06,940, divided into 27,20,694 equity shares of Rs.10 each. The total diluted share and voting capital post-acquisition is reported as Rs. 4,71,06,940, divided into 47,10,694 equity shares of Rs.10 each.

The disclosure confirms that Kamath Technology LLP does not belong to the promoter or promoter group of the target company. The shares of Photon Capital Advisors Limited are listed on BSE Limited under the scrip code 509084.